Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture › C12P 21 - Preparation of peptides or proteins
Patents for C12P 21 - Preparation of peptides or proteins (112,499)
10/2010
10/27/2010CN101874041A Modified antibody constant region
10/27/2010CN101870996A Process for preparing skin longevity factor peptide
10/27/2010CN101870995A Process for preparing collagen tripeptide
10/27/2010CN101870963A Recombinant Newcastle disease virus attenuated vaccine strain for expressing dog interferon (alpha, beta or gamma)
10/27/2010CN101870735A Novel high-glycosylation erythropoietin immune fusion protein
10/27/2010CN101870729A Coagulation factor vii polypeptides
10/27/2010CN101142315B Method for preparing dipeptide
10/26/2010USRE41894 Hepatitis C inhibitor tri-peptides
10/26/2010US7820877 Human heavy chain variable regions, human kappa light chain variable regions and encodes only mu isotype; human kappa light chain variable regions and encodes mu and gamma-2 isotypes; double-inactivated mouse Ig locus
10/26/2010US7820807 can bind to and stimulate professional and non-professional human antigen-presenting cells, enhance the stimulatory effect of CD40L on CD40 positive cells and/or induce phenotypical maturation of monocyte derived dendritic cells
10/26/2010US7820797 Glycolipopeptide antibodies
10/26/2010US7820793 IFN-λ polypeptides and compositions
10/26/2010US7820442 expression of AID in Escherichia coli gives a mutator phenotype yielding DNA nucleotide transitions at dG/dC; mutation frequency is enhanced by deficiency in uracil-DNA glycosylase indicating that AID acts by deaminating dC residues in DNA
10/26/2010US7820441 Production of viral vectors
10/26/2010US7820424 Modified hydrolase for use as template for inverse polymerase chain reaction
10/26/2010US7820421 Ketoreductases and uses thereof
10/26/2010US7820411 Escherichia coli-derived vaccine and therapy against botulism
10/26/2010US7820410 Proteins with high immunoreactivity and method for their production
10/26/2010US7820408 isolated DNA methyltransferase; catalyzes the methylation of cytosine in the sequence GCNGC
10/26/2010US7820406 Expression of heterologous functional oxygen-sensitive proteins in filamentous cyanobacteria
10/26/2010US7820400 Tumor-associated marker
10/26/2010US7820397 Human or rodent Stromal Interacting Molecule (STIM) 1 protein; for treatment of diseases associated with calcium dysregulation
10/26/2010US7820384 Methods and compositions for protein expression and purification
10/26/2010US7820170 monoclonal antibody exhibit antagonist activity of the anti-CD40 antibody; antiproliferative agents; controlling cell differentiation; anticarcinogenic agents; Hodgkin's disease, leukemias
10/26/2010US7820169 inhibiting the activity of tumor necrosis factor TNF in a patient having rheumatoid arthritis or psoriatic arthritis, by administering a composition comprising an effective amount of human anti-TNF antibody comprising a heavy chain variable region comprising SEQ ID NO:7 and a light chain variable
10/26/2010US7820162 Methods for chemically synthesizing immunoglobulin chimeric proteins
10/26/2010CA2579391C Anti-a33 antibody
10/26/2010CA2443840C Cripto blocking antibodies and uses thereof
10/26/2010CA2351887C Psca: prostate stem cell antigen and uses thereof
10/26/2010CA2326501C Binding molecules derived from immunoglobulins which do not trigger complement mediated lysis
10/26/2010CA2319211C Recombinant proteins derived from hgf and msp
10/26/2010CA2197717C Mycobacteria functional screening and/or expression vectors
10/26/2010CA2178941C Transgenic production of antibodies in milk
10/21/2010WO2010099536A3 Engineered proteins with high affinity for dota chelates
10/21/2010WO2010099153A3 Metabolic engineering of a galactose assimilation pathway in the glycoengineered yeast pichia pastoris
10/21/2010WO2008122434A8 Bis-met histones
10/21/2010US20100269221 Novel Bacillus Thuringiensis Gene with Lepidopteran Activity
10/21/2010US20100269184 Apo-2DcR
10/21/2010US20100267936 PROCESS FOR CORRECTION OF A DISULFIDE MISFOLD IN Fc MOLECULES
10/21/2010US20100267934 Stable igg4 antibodies
10/21/2010US20100267931 Heterologous expression of neisserial proteins
10/21/2010US20100267846 Molecular delivery vehicle
10/21/2010US20100267816 Human anti-amyloid beta peptide antibody and fragment of said antibody
10/21/2010US20100267711 Method of enhancing cellular production of molecular chaperone, hydroxylamine derivatives useful for enhancing the chaperone production and the preparation thereof
10/21/2010US20100267648 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides
10/21/2010US20100267623 Peptides with capacity to bind to scurfin and applications
10/21/2010US20100267145 Immunocompetent cell having anti-cd38 antibody on its cell surface
10/21/2010US20100267088 Inha promoters
10/21/2010US20100267087 MUTANT PYRROLYSYL-tRNA SYNTHETASE, AND METHOD FOR PRODUCTION OF PROTEIN HAVING NON-NATURAL AMINO ACID INTEGRATED THEREIN BY USING THE SAME
10/21/2010US20100267086 Optimized Nucleic Acid Sequences For The Expression of VB4-845
10/21/2010US20100267085 Novel pseudochlorococcum species and uses therefor
10/21/2010US20100267084 Protein glycosylation modification in methylotrophic yeast
10/21/2010US20100267083 Modified Cytochrome P450 Monooxygenases
10/21/2010US20100267082 Novel peptide-forming enzyme gene
10/21/2010US20100267057 Cell Surface Display, Screening and Production of Proteins of Interest
10/21/2010US20100267022 Monocyte-derived nucleic acids and related compositions and methods
10/21/2010US20100266673 Compositions and methods for the delivery of nitric oxide
10/21/2010US20100266639 Expression system
10/21/2010US20100266617 Antibodies to human programmed death receptor pd-1
10/21/2010US20100266614 Ultra high affinity neutralizing antibodies
10/21/2010US20100266613 Anti-tnf-alpha antibodies and their uses
10/21/2010US20100266609 Antibody Molecules Which Bind IL-17A and IL-17F
10/21/2010US20100266601 Antibodies that inhibit tslp activity
10/21/2010US20100266575 SOLUBLE FMS-LIKE TYROSINE KINASE-1 (sFLT-1) ANTIBODY AND RELATED COMPOSITION, KIT, METHODS OF USING, AND MATERIALS AND METHOD FOR MAKING
10/21/2010US20100266551 Adeno-associated viral vectors for the expression of dysferlin
10/21/2010US20100266536 new type of consensus interferon and preparation method thereof
10/21/2010US20100266531 Il-17 binding proteins
10/21/2010US20100266493 Agonist antibodies against tshr
10/20/2010EP2241625A1 Proteinase K resistant surface protein of neisseria meningitidis
10/20/2010EP2241623A2 Monoclonal antibody against a human cytokine receptor
10/20/2010EP2241622A2 Human trk receptors and their derivatives
10/20/2010EP2241578A1 Anti-cldn6 antibody
10/20/2010EP2241331A2 Novel anti-DC-SIGN antibodies
10/20/2010EP2241329A2 Anti-interleukin-9 antibody or anti-interleukin-9 receptor antibody for treating bronchial hyper-responsiveness
10/20/2010EP2240578A1 Substantially animal protein-free recombinant furin and methods for producing same
10/20/2010EP2240199A1 Influenza b vaccines
10/20/2010EP1866415B1 A cysteine-containing peptide tag for site-specific conjugation of proteins
10/20/2010EP1737946B1 Method for culturing the nitrile hydratase-producing strain rodococcus rhodochrous m33
10/20/2010EP1407269B1 A method for diagnosing a person having multiple sclerosis
10/20/2010EP1206554B2 Activatable recombinant neurotoxins
10/20/2010CN101864472A Preparation method of small molecular soybean protein polypeptide liquid nitrogen source for brewing beer
10/20/2010CN101864424A Method for efficient secretory expression and purification of recombinant 4Abeta15 in pichia pastoris
10/20/2010CN101864422A Satellite composition type expression promoter of malvastrum yellow vein viruses
10/20/2010CN101864371A Homologous recombination construction double-GAL4 genotype industrial saccharomyces cerevisiae and application thereof
10/20/2010CN101863985A Recombinant human fusion Tat cytoglobulin and application thereof in treating liver cancer
10/20/2010CN101863982A Fusion protein for increasing blood platelets and preparation method thereof
10/20/2010CN101862443A Preparation method of enramycin premix
10/19/2010US7816578 produces antibodies comprising two human immunoglobulin loci for use in the treatmnent of cardiovascular, infections, cancer and autoimmune disorders
10/19/2010US7816504 PUFA polyketide synthase systems and uses thereof
10/19/2010US7816497 Compositions and methods for inhibiting drusen complement components C3a and C5a for the treatment of age-related macular degeneration
10/19/2010US7816496 Carbonic anhydrase specific immunoglobulin for use in diagnosis, prevention and treatment of cell proliferative disorders
10/19/2010US7816493 Carbonic anhydrase for use diagnostic/prognostic tool in detectingf cell proliferative disorders of breast
10/19/2010US7816491 Ordered biological nanostructures formed from chaperonin polypeptides
10/19/2010US7816335 Therapeutic compounds and methods
10/19/2010US7816319 Methods and products for manipulating uncoupling protein expression
10/19/2010US7816117 Prokaryotic host cells for expressing proteins rich in disulfide bonds
10/19/2010US7816113 Recombinant, heat resistant pullulanase or isoamylase for use in conversion of amylopectin and/or glycogen into high fructose syrups, high maltose syrups, maltodextrins, amylose and/or G4-G6 oligosaccharides for use in food processing
10/19/2010US7816111 Enhanced heat resistant glucose dehydrogenase for coupling to oxido- or reductase enzymes to produce synthetic organic chemicals or precursors
10/19/2010US7816108 producing ethanol by providing a polypeptide having alpha-amylase activity, contacting a starch-comprising composition with the polypeptide to produce a sugar, and fermenting the sugar to produce ethanol
10/19/2010US7816103 Protein having amino acid sequence in SEQ ID No.: 1 of the Sequence Listing derived from human MP52, and a dimer protein homodimer protein described above can be obtained by constructing a plasmid containing DNA coding amino acid; for treating cartilage and bone diseases
1 ... 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 ... 1125